Kintu K, Malaba T, Nakibuka J, et al. RCT of Dolutegravir vs Efavirenz-based therapy initiated in late pregnancy: DOLPHIN-2. CROI 2019, abstract 40-LB.
‘Real life’ effectiviteit en veiligheid van SOF/VEL/VOX bij HCV na falen op DAA
nov 2019 | Hepatitis